Arzan Financial Group for Financing & Investment Company and SANAM Group Holding Company have announced that subsidiaries of each have acquired stakes in the OTC 488 National Medical Consumable Industries Company (NATMED).

According to a statement issued by Boursa Kuwait on Thursday:

• A subsidiary of Sanam Holding Group acquired a 7.61% stake in NATMED, with a transaction value of KWD 916,070. The deal was executed in accordance with Boursa Kuwait’s Over-the-Counter (OTC) trading procedures.
Sanam noted that the financial impact on its consolidated financial statements includes:
• An increase in investments in associates by KWD 936,074, representing the transaction value plus associated expenses.
•  A rise in operating income from associate companies results.
This impact will be reflected in the consolidated financial statements as of September 30, 2025.
• Meanwhile, Arzan Financial Group confirmed that a subsidiary has acquired a 67.39% stake in NATMED for KWD 8,095,605.
Arzan disclosed that the financial impact on its consolidated results includes:
• An increase of KWD of 8,272,640 in investments in associates, including transaction-related expenses.
•   Higher operating revenues are derived from the performance of associate companies.
Arzan added that the financial impact of this acquisition will appear in its consolidated financial statements for the period ending September 30, 2025.